source
- Cytokinetics succeeds where Bristol Myers failed in heart muscle diseaseCytokinetics’ pill for a heart muscle disorder called hypertrophic cardiomyopathy could see its addressable market double after it succeeded in a pivotal trial for another form of the disease. The…Endpoints · 2mo ago↗ source
- Vertex drops mRNA cystic fibrosis program over 'tolerability' issuesVertex Pharmaceuticals said it has dropped development of an mRNA-based cystic fibrosis therapy after facing challenges similar to those that have troubled other parts of the field in delivering th…Endpoints · 2mo ago↗ source
- FDA search for new CBER head focused on small group of final candidatesThe FDA has narrowed its search for a new leader of its Center for Biologics Evaluation and Research to three or four final candidates, according to a person familiar with the matter. The agency ho…